Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher T Ritchlin

Showing results (131-140 of 217) with videos related to

Pageof 22
Sort By:
The Journal of Rheumatology|June 17, 2015
Prevalence and Clinical Characteristics of Psoriatic Arthritis in JapanYuri Ohara, Mitsumasa Kishimoto, Naoho Takizawa, et al.
RMD Open|November 19, 2021
Clinically relevant patient clusters identified by machine learning from the clinical development programme of secukinumab in psoriatic arthritisEffie Pournara, Matthias Kormaksson, Peter Nash, et al.
The Journal of Rheumatology. Supplement|June 3, 2018
GRAPPA 2017 Project ReportKristina Callis Duffin, Oliver FitzGerald, Artie Kavanaugh, et al.
Seminars in Arthritis and Rheumatism|December 12, 2013
Proceedings of the 5th annual perspectives in rheumatic diseasesDaniel E Furst, Brian Mandell, Leonard H Calabrese, et al.
ACR Open Rheumatology|August 9, 2023
Guselkumab Modulates Differentially Expressed Genes in Blood of Patients With Psoriatic Arthritis: Results from Two Phase 3, Randomized, Placebo-Controlled TrialsStefan Siebert, Kristen M Sweet, Christopher T Ritchlin, et al.
Arthritis Care & Research|August 18, 2019
Composite Measures of Disease Activity in Psoriatic Arthritis: Comparative Instrument Performance Based on the Efficacy of Guselkumab in an Interventional Phase II TrialPhilip S Helliwell, Atul Deodhar, Alice B Gottlieb, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 25, 2017
Brief Report: Treatment of Tumor Necrosis Factor-Transgenic Mice With Anti-Tumor Necrosis Factor Restores Lymphatic Contractions, Repairs Lymphatic Vessels, and May Increase Monocyte/Macrophage EgressEchoe M Bouta, Igor Kuzin, Karen de Mesy Bentley, et al.
Arthritis and Rheumatism|August 29, 2009
Inhibition of lymphangiogenesis and lymphatic drainage via vascular endothelial growth factor receptor 3 blockade increases the severity of inflammation in a mouse model of chronic inflammatory arthritisRuolin Guo, Quan Zhou, Steven T Proulx, et al.
ACR Open Rheumatology|September 10, 2020
Tofacitinib in Patients With Psoriatic Arthritis and Metabolic Syndrome: A Post hoc Analysis of Phase 3 StudiesChristopher T Ritchlin, Jon T Giles, Alexis Ogdie, et al.
Plos One|July 5, 2024
High-throughput micro-CT analysis identifies sex-dependent biomarkers of erosive arthritis in TNF-Tg mice and differential response to anti-TNF therapyH Mark Kenney, Kiana L Chen, Lindsay Schnur, et al.
Pageof 22

Showing results (131-140 of 217) with videos related to

Sort By:
Pageof 22
The Journal of Rheumatology|June 17, 2015
Prevalence and Clinical Characteristics of Psoriatic Arthritis in JapanYuri Ohara, Mitsumasa Kishimoto, Naoho Takizawa, et al.
RMD Open|November 19, 2021
Clinically relevant patient clusters identified by machine learning from the clinical development programme of secukinumab in psoriatic arthritisEffie Pournara, Matthias Kormaksson, Peter Nash, et al.
The Journal of Rheumatology. Supplement|June 3, 2018
GRAPPA 2017 Project ReportKristina Callis Duffin, Oliver FitzGerald, Artie Kavanaugh, et al.
Seminars in Arthritis and Rheumatism|December 12, 2013
Proceedings of the 5th annual perspectives in rheumatic diseasesDaniel E Furst, Brian Mandell, Leonard H Calabrese, et al.
ACR Open Rheumatology|August 9, 2023
Guselkumab Modulates Differentially Expressed Genes in Blood of Patients With Psoriatic Arthritis: Results from Two Phase 3, Randomized, Placebo-Controlled TrialsStefan Siebert, Kristen M Sweet, Christopher T Ritchlin, et al.
Arthritis Care & Research|August 18, 2019
Composite Measures of Disease Activity in Psoriatic Arthritis: Comparative Instrument Performance Based on the Efficacy of Guselkumab in an Interventional Phase II TrialPhilip S Helliwell, Atul Deodhar, Alice B Gottlieb, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 25, 2017
Brief Report: Treatment of Tumor Necrosis Factor-Transgenic Mice With Anti-Tumor Necrosis Factor Restores Lymphatic Contractions, Repairs Lymphatic Vessels, and May Increase Monocyte/Macrophage EgressEchoe M Bouta, Igor Kuzin, Karen de Mesy Bentley, et al.
Arthritis and Rheumatism|August 29, 2009
Inhibition of lymphangiogenesis and lymphatic drainage via vascular endothelial growth factor receptor 3 blockade increases the severity of inflammation in a mouse model of chronic inflammatory arthritisRuolin Guo, Quan Zhou, Steven T Proulx, et al.
ACR Open Rheumatology|September 10, 2020
Tofacitinib in Patients With Psoriatic Arthritis and Metabolic Syndrome: A Post hoc Analysis of Phase 3 StudiesChristopher T Ritchlin, Jon T Giles, Alexis Ogdie, et al.
Plos One|July 5, 2024
High-throughput micro-CT analysis identifies sex-dependent biomarkers of erosive arthritis in TNF-Tg mice and differential response to anti-TNF therapyH Mark Kenney, Kiana L Chen, Lindsay Schnur, et al.
Pageof 22